Optimization of the solvent and in vivo administration route of auranofin in a syngeneic non-small cell lung cancer and glioblastoma mouse model
Source
Pharmaceutics - ISSN 1999-4923-14:12 (2022) p. 1-18
Auranofin and cold atmospheric plasma synergize to trigger distinct cell death mechanisms and immunogenic responses in glioblastoma
Source
Cells - ISSN 2073-4409-10:11 (2021) p. 1-22
Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer
Source
Redox Biology - ISSN 2213-2317-42 (2021) p.
Endogenous antioxidants in the prognosis and treatment of lung cancer
Source
Cancer : oxidative stress and dietary antioxidants / Preedy, V.R. [edit.]; Patel, V.B. [edit.]-p. 39-48
Characterization of acquired nutlin-3 resistant non-small cell lung cancer cells
Source
- ISSN 2578-532X-4:1 (2021) p. 233-243